CAS: 1357171-62-0
ML228
CAS:1357171-62-0
ML228 activates HIF pathway and VEGF, with EC50 of 1μM, effective in vitro.
Formula:
C27H21N5
Purity:
99.03%
Color and Shape:
Solid
Molecular weight:
415.49
Ref: TM-T7836
1mg | 44.00 € | ||
5mg | 96.00 € | ||
10mg | 157.00 € | ||
25mg | 334.00 € | ||
50mg | 524.00 € | ||
100mg | 737.00 € | ||
1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
N-([1,1'-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine
Controlled ProductCAS:1357171-62-0
Applications N-([1,1'-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine is an activator of the hypoxia inducible factor (HIF) pathway. References Theriault, J.R., …
Formula:
C27H21N5
Color and Shape:
Neat
Molecular weight:
415.49
Ref: TR-B397960
1mg | 236.00 € | ||
5mg | 887.00 € | ||
10mg | 1,404.00 € |
Estimated delivery in United States, on Friday 20 Dec 2024
N-([1,1'-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine
CAS:1357171-62-0
N-([1,1'-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine (NBTZ) is a potent and selective inhibitor of human VEGF. It blocks the binding …
Formula:
C27H21N5
Purity:
Min. 95%
Molecular weight:
415.5 g/mol
Ref: 3D-HEC17162
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
N-([1,1'-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine
CAS:1357171-62-0
Formula:
C27H21N5
Purity:
98%
Color and Shape:
Solid
Molecular weight:
415.4891
Ref: IN-DA009CJ7
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
200mg | Discontinued | Request information |